NCT04365023 2026-02-13
TNE-bien-DIF
Assistance Publique - Hôpitaux de Paris
Completed
Clinical Trials
50 trialsNCT05844332 2025-12-22
LUTATHERA Injection General Use Result Survey
Novartis
Completed
NCT06358001 2025-09-22
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Completed
NCT03576040 2025-06-25
GAPET-NET
University Hospital, Brest
Completed
NCT06983106 2025-05-21
GEP-NENs
Tongji Hospital
Completed
NCT04986085 2025-03-28
NUTRIGETNE
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT06853457 2025-03-03
A Transfer Learning Radiomics Model for Predicting Response to Initial Transarterial Embolization in Patients with Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT05246319 2025-02-12
TEGRELE
Central Hospital, Nancy, France
Completed
NCT06779708 2025-01-16
ECHO-NET
Istituto Clinico Humanitas
Completed
NCT06253897 2024-12-24
BackSOM
Ipsen
Completed
NCT04649580 2024-12-17
PREF-NET
Ipsen
Completed
NCT03852693 2024-11-13
SurvivApp
Insel Gruppe AG, University Hospital Bern
Completed
NCT03223428 2024-07-24
RELAX
TerSera Therapeutics LLC
Completed
NCT02282059 2024-06-20
The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
Pfizer
Completed
NCT01398306 2024-05-06
BANN
University Medical Center Groningen
Completed
NCT02147106 2024-05-06
VIDEO-NET
University Medical Center Groningen
Completed
NCT02507908 2024-05-06
5-HIAA
University Medical Center Groningen
Completed
NCT02646644 2024-05-06
HET-NET
University Medical Center Groningen
Completed
NCT02815969 2024-05-06
The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors
University Medical Center Groningen
Completed
NCT06143605 2023-11-22
Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors
Sun Yat-sen University
Completed
NCT05528614 2023-11-08
ReSiPaTNE
University Hospital, Strasbourg, France
Completed
NCT05816720 2023-04-18
Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
Novartis
Completed
NCT01423734 2023-01-23
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Memorial Sloan Kettering Cancer Center
Completed
NCT05565066 2022-12-01
A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Huazhong University of Science and Technology
Completed
NCT02102893 2022-07-29
Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan
National Health Research Institutes, Taiwan
Completed
NCT02586844 2022-04-14
NET-SEQ
University Health Network, Toronto
Completed
NCT02630654 2021-12-07
EXPLAIN
Ipsen
Completed
NCT02948946 2021-08-04
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT02810600 2021-05-18
PET/Ga68
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Completed
NCT02973204 2021-04-28
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus
Completed
NCT04780737 2021-03-03
Prophylactic Cholecystectomy is Not Mandatory in Patients Candidate to the Resection for Small Intestine Neuroendocrine Neoplasms: a Propensity Score-matched and Cost-minimization Analysis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Completed
NCT04753229 2021-02-18
TNE-P-Ki
Institut Paoli-Calmettes
Completed
NCT04207762 2021-01-20
18F-AmBF3-TATE PET/CT for Imaging NET Patients
British Columbia Cancer Agency
Completed
NCT01234168 2020-11-05
SYMNET
Ipsen
Completed
NCT03562091 2020-08-28
OPERA
Ipsen
Completed
NCT02730104 2020-06-26
Community-based Neuroendocrine Tumor (NET) Research Study
Ipsen
Completed
NCT03112694 2020-06-02
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Ipsen
Completed
NCT03840720 2020-04-28
The Patient's Journey - the Time to Final Diagnosis in Patients With SiNET
Vastra Gotaland Region
Completed
NCT02841865 2020-03-24
CRIPNET
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT03948841 2019-05-14
NETMRI
CHU de Reims
Completed
NCT03791346 2019-04-18
PanTEN
University Hospital, Montpellier
Completed
NCT01840449 2019-01-14
SOPRANo
Ipsen
Completed
NCT00747786 2019-01-07
Non Interventional Post Marketing Programme in Neuroendocrine Tumours
Ipsen
Completed
NCT03017690 2018-12-21
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Ipsen
Completed
NCT03220087 2018-12-21
RECOSY
Ipsen
Completed
NCT03592940 2018-07-19
NetNutr
Federico II University
Completed
NCT00815620 2017-03-21
BESTTHERAPYNET
Zentralklinik Bad Berka
Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT01338090 2012-04-03
NETPET
University Medical Center Groningen
Completed
NCT00789841 2010-10-26
Gastrointestinal Motility in Patients With Neuroendocrine Tumors
University of Aarhus
Completed